These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1227 related items for PubMed ID: 21360491
21. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, Dougados M, Baldassare A, Ferraccioli G, Chubick A, Udell J, Cravets MW, Agarwal S, Cooper S, Magrini F. Arthritis Rheum; 2007 Dec; 56(12):3896-908. PubMed ID: 18050221 [Abstract] [Full Text] [Related]
22. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D. Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396 [Abstract] [Full Text] [Related]
23. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial. Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU, GO-AFTER study investigators. Lancet; 2009 Jul 18; 374(9685):210-21. PubMed ID: 19560810 [Abstract] [Full Text] [Related]
24. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V. Arthritis Rheum; 2004 Feb 18; 50(2):364-71. PubMed ID: 14872477 [Abstract] [Full Text] [Related]
25. Randomized, double-blind, placebo-controlled, comparative study of human anti-TNF antibody adalimumab in combination with methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis. Chen DY, Chou SJ, Hsieh TY, Chen YH, Chen HH, Hsieh CW, Lan JL. J Formos Med Assoc; 2009 Apr 18; 108(4):310-9. PubMed ID: 19369178 [Abstract] [Full Text] [Related]
26. The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study. Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Lexberg AS, Rødevand E, Kalstad S, Mikkelsen K, Kvien TK. Ann Rheum Dis; 2014 Jan 18; 73(1):132-7. PubMed ID: 23291385 [Abstract] [Full Text] [Related]
27. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Weinblatt ME, Bingham CO, Mendelsohn AM, Kim L, Mack M, Lu J, Baker D, Westhovens R. Ann Rheum Dis; 2013 Mar 18; 72(3):381-9. PubMed ID: 22661646 [Abstract] [Full Text] [Related]
30. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ. Arthritis Rheum; 2004 Feb 18; 50(2):353-63. PubMed ID: 14872476 [Abstract] [Full Text] [Related]
31. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. Kavanaugh A, St Clair EW, McCune WJ, Braakman T, Lipsky P. J Rheumatol; 2000 Apr 18; 27(4):841-50. PubMed ID: 10782805 [Abstract] [Full Text] [Related]
32. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A, Pediatric Rheumatology Collaborative Study Group, Pediatric Rheumatology International Trials Organisation. N Engl J Med; 2008 Aug 21; 359(8):810-20. PubMed ID: 18716298 [Abstract] [Full Text] [Related]
33. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G. Arthritis Rheum; 2002 May 21; 46(5):1164-70. PubMed ID: 12115219 [Abstract] [Full Text] [Related]
36. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Mease PJ, Gladman DD, Keystone EC, Alefacept in Psoriatic Arthritis Study Group. Arthritis Rheum; 2006 May 21; 54(5):1638-45. PubMed ID: 16646026 [Abstract] [Full Text] [Related]
37. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis. Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B. J Rheumatol; 2006 Feb 21; 33(2):234-43. PubMed ID: 16465653 [Abstract] [Full Text] [Related]